Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Morphic Holding Inc (MORF)

Morphic Holding Inc (MORF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,347,809
  • Shares Outstanding, K 36,451
  • Annual Sales, $ 44,950 K
  • Annual Income, $ -45,000 K
  • 60-Month Beta 1.20
  • Price/Sales 52.48
  • Price/Cash Flow N/A
  • Price/Book 6.58
Trade MORF with:

Options Overview Details

View History
  • Implied Volatility 63.19%
  • Historical Volatility 42.19%
  • IV Percentile 67%
  • IV Rank 68.75%
  • IV High 77.53% on 07/20/21
  • IV Low 31.66% on 07/19/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 30
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 0

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.76
  • Number of Estimates 2
  • High Estimate -0.67
  • Low Estimate -0.85
  • Prior Year 0.17
  • Growth Rate Est. (year over year) -547.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
59.01 +9.15%
on 09/09/21
68.32 -5.72%
on 09/15/21
+3.57 (+5.87%)
since 08/24/21
3-Month
51.00 +26.29%
on 08/04/21
68.32 -5.72%
on 09/15/21
+4.84 (+8.12%)
since 06/24/21
52-Week
24.92 +158.47%
on 09/25/20
93.00 -30.74%
on 03/01/21
+39.35 (+157.02%)
since 09/24/20

Most Recent Stories

More News
New Strong Sell Stocks for September 16th

CLMT, FANH, and MORF have been added to the Zacks Rank #5 (Strong Sell) List on September 16, 2021.

CLMT : 7.58 (-1.94%)
FANH : 12.35 (+2.15%)
MORF : 64.41 (-0.46%)
Morphic Therapeutic Announces Appointment of Nisha Nanda, Ph.D., to Board of Directors

Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced the appointment of...

MORF : 64.41 (-0.46%)
Morphic Holding, Inc. (MORF) Reports Q2 Loss, Misses Revenue Estimates

Morphic Holding, Inc. (MORF) delivered earnings and revenue surprises of -40.00% and -35.87%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

MORF : 64.41 (-0.46%)
Earnings Preview: Morphic Holding, Inc. (MORF) Q2 Earnings Expected to Decline

Morphic Holding, Inc. (MORF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MORF : 64.41 (-0.46%)
Morphic Therapeutic to Host Analyst and Investor Call on July 9, 2021

Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced it will host a webcast...

MORF : 64.41 (-0.46%)
Strength Seen in Morphic Holding, Inc. (MORF): Can Its 6% Jump Turn into More Strength?

Morphic Holding, Inc. (MORF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near...

MORF : 64.41 (-0.46%)
Morphic Therapeutic to Present at the Jefferies Virtual Healthcare Conference

Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that members of the...

MORF : 64.41 (-0.46%)
Morphic Holding Becomes Oversold (MORF)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

MORF : 64.41 (-0.46%)
Morphic Holding, Inc. (MORF) Reports Q1 Loss, Misses Revenue Estimates

Morphic Holding, Inc. (MORF) delivered earnings and revenue surprises of -6.78% and -45.58%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

MORF : 64.41 (-0.46%)
Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors

Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing oral integrin therapies, today announced the appointment of Susannah Gray to its Board of Directors. Ms. Gray is an accomplished leader...

MORF : 64.41 (-0.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Morphic Holding Inc. is a biopharmaceutical company. It focuses on the discovery and development of oral small-molecule integrin therapeutics for autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer. Morphic Holding Inc. is based in Waltham, Massachusetts.

See More

Key Turning Points

3rd Resistance Point 67.15
2nd Resistance Point 66.18
1st Resistance Point 65.30
Last Price 64.41
1st Support Level 63.44
2nd Support Level 62.47
3rd Support Level 61.59

See More

52-Week High 93.00
Fibonacci 61.8% 66.99
Last Price 64.41
Fibonacci 50% 58.96
Fibonacci 38.2% 50.93
52-Week Low 24.92

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar